vs

Side-by-side financial comparison of Babcock & Wilcox Enterprises, Inc. (BW) and Core Laboratories Inc. (CLB). Click either name above to swap in a different company.

Core Laboratories Inc. is the larger business by last-quarter revenue ($121.8M vs $113.4M, roughly 1.1× Babcock & Wilcox Enterprises, Inc.). On growth, Babcock & Wilcox Enterprises, Inc. posted the faster year-over-year revenue change (0.6% vs -1.4%). Core Laboratories Inc. produced more free cash flow last quarter ($517.0K vs $-7.2M). Over the past eight quarters, Core Laboratories Inc.'s revenue compounded faster (-3.4% CAGR vs -16.9%).

Babcock & Wilcox Enterprises, Inc. is an American energy technology and service provider that is active and has operations in many international markets with its headquarters in Akron, Ohio. Historically, the company is best known for their steam boilers.

Abbott Laboratories, commonly known as Abbott, is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois. The company produces pharmaceuticals for sale outside the United States, diagnostic products, nutritional products, and medical devices.

BW vs CLB — Head-to-Head

Bigger by revenue
CLB
CLB
1.1× larger
CLB
$121.8M
$113.4M
BW
Growing faster (revenue YoY)
BW
BW
+2.1% gap
BW
0.6%
-1.4%
CLB
More free cash flow
CLB
CLB
$7.7M more FCF
CLB
$517.0K
$-7.2M
BW
Faster 2-yr revenue CAGR
CLB
CLB
Annualised
CLB
-3.4%
-16.9%
BW

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
BW
BW
CLB
CLB
Revenue
$113.4M
$121.8M
Net Profit
$5.1M
Gross Margin
20.6%
Operating Margin
0.2%
1.5%
Net Margin
4.2%
Revenue YoY
0.6%
-1.4%
Net Profit YoY
EPS (diluted)
$0.11
$0.11

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BW
BW
CLB
CLB
Q1 26
$121.8M
Q4 25
$113.4M
$138.3M
Q3 25
$149.0M
$134.5M
Q2 25
$144.1M
$130.2M
Q1 25
$181.2M
$123.6M
Q4 24
$112.7M
$129.2M
Q3 24
$152.6M
$134.4M
Q2 24
$151.4M
$130.6M
Net Profit
BW
BW
CLB
CLB
Q1 26
$5.1M
Q4 25
$4.9M
Q3 25
$35.1M
$14.2M
Q2 25
$-58.5M
$10.6M
Q1 25
$-22.0M
$-154.0K
Q4 24
$-63.1M
$7.4M
Q3 24
$-5.3M
$11.7M
Q2 24
$25.4M
$9.0M
Gross Margin
BW
BW
CLB
CLB
Q1 26
Q4 25
20.6%
20.8%
Q3 25
24.9%
22.0%
Q2 25
30.0%
20.3%
Q1 25
22.1%
19.5%
Q4 24
16.7%
17.8%
Q3 24
23.7%
20.5%
Q2 24
21.8%
21.2%
Operating Margin
BW
BW
CLB
CLB
Q1 26
1.5%
Q4 25
0.2%
11.5%
Q3 25
4.4%
15.6%
Q2 25
5.6%
11.7%
Q1 25
3.2%
3.6%
Q4 24
-8.1%
11.0%
Q3 24
1.0%
14.7%
Q2 24
-2.9%
12.3%
Net Margin
BW
BW
CLB
CLB
Q1 26
4.2%
Q4 25
3.6%
Q3 25
23.5%
10.6%
Q2 25
-40.6%
8.2%
Q1 25
-12.1%
-0.1%
Q4 24
-56.0%
5.7%
Q3 24
-3.5%
8.7%
Q2 24
16.8%
6.9%
EPS (diluted)
BW
BW
CLB
CLB
Q1 26
$0.11
Q4 25
$0.11
$0.11
Q3 25
$0.30
$0.30
Q2 25
$-0.63
$0.22
Q1 25
$-0.26
$0.00
Q4 24
$-0.73
$0.15
Q3 24
$-0.10
$0.25
Q2 24
$0.24
$0.19

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BW
BW
CLB
CLB
Cash + ST InvestmentsLiquidity on hand
$89.5M
$22.8M
Total DebtLower is stronger
Stockholders' EquityBook value
$-131.5M
$275.1M
Total Assets
$662.9M
$587.7M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BW
BW
CLB
CLB
Q1 26
$22.8M
Q4 25
$89.5M
$22.7M
Q3 25
$25.2M
$25.6M
Q2 25
$23.4M
$31.2M
Q1 25
$23.5M
$22.1M
Q4 24
$26.9M
$19.2M
Q3 24
$30.6M
$21.5M
Q2 24
$95.5M
$17.7M
Total Debt
BW
BW
CLB
CLB
Q1 26
Q4 25
$110.3M
Q3 25
$114.1M
Q2 25
$124.6M
Q1 25
$124.4M
Q4 24
$126.1M
Q3 24
$139.9M
Q2 24
$147.6M
Stockholders' Equity
BW
BW
CLB
CLB
Q1 26
$275.1M
Q4 25
$-131.5M
$266.0M
Q3 25
$-232.2M
$271.3M
Q2 25
$-309.2M
$261.3M
Q1 25
$-303.0M
$253.4M
Q4 24
$-283.8M
$246.6M
Q3 24
$-203.7M
$250.7M
Q2 24
$-198.9M
$240.3M
Total Assets
BW
BW
CLB
CLB
Q1 26
$587.7M
Q4 25
$662.9M
$584.0M
Q3 25
$657.9M
$591.4M
Q2 25
$703.5M
$602.1M
Q1 25
$719.7M
$591.5M
Q4 24
$727.0M
$585.1M
Q3 24
$804.6M
$600.5M
Q2 24
$849.1M
$597.8M
Debt / Equity
BW
BW
CLB
CLB
Q1 26
Q4 25
0.41×
Q3 25
0.42×
Q2 25
0.48×
Q1 25
0.49×
Q4 24
0.51×
Q3 24
0.56×
Q2 24
0.61×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BW
BW
CLB
CLB
Operating Cash FlowLast quarter
$-3.0M
$4.0M
Free Cash FlowOCF − Capex
$-7.2M
$517.0K
FCF MarginFCF / Revenue
-6.3%
0.4%
Capex IntensityCapex / Revenue
3.7%
Cash ConversionOCF / Net Profit
0.77×
TTM Free Cash FlowTrailing 4 quarters
$-85.7M
$22.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BW
BW
CLB
CLB
Q1 26
$4.0M
Q4 25
$-3.0M
$7.9M
Q3 25
$-32.1M
$8.5M
Q2 25
$-25.3M
$13.9M
Q1 25
$-8.5M
$6.7M
Q4 24
$-22.5M
$20.6M
Q3 24
$-69.5M
$13.1M
Q2 24
$-11.8M
$17.1M
Free Cash Flow
BW
BW
CLB
CLB
Q1 26
$517.0K
Q4 25
$-7.2M
$5.0M
Q3 25
$-37.6M
$6.5M
Q2 25
$-28.1M
$10.4M
Q1 25
$-12.8M
$3.9M
Q4 24
$-23.6M
$17.4M
Q3 24
$-71.6M
$10.4M
Q2 24
$-16.4M
$14.3M
FCF Margin
BW
BW
CLB
CLB
Q1 26
0.4%
Q4 25
-6.3%
3.6%
Q3 25
-25.3%
4.8%
Q2 25
-19.5%
8.0%
Q1 25
-7.1%
3.1%
Q4 24
-20.9%
13.4%
Q3 24
-46.9%
7.7%
Q2 24
-10.8%
10.9%
Capex Intensity
BW
BW
CLB
CLB
Q1 26
Q4 25
3.7%
2.1%
Q3 25
3.7%
1.5%
Q2 25
1.9%
2.7%
Q1 25
2.4%
2.3%
Q4 24
1.0%
2.5%
Q3 24
1.4%
2.0%
Q2 24
3.0%
2.2%
Cash Conversion
BW
BW
CLB
CLB
Q1 26
0.77×
Q4 25
1.61×
Q3 25
-0.92×
0.60×
Q2 25
1.31×
Q1 25
Q4 24
2.78×
Q3 24
1.12×
Q2 24
-0.46×
1.90×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BW
BW

Construction$98.8M87%
Other$14.6M13%

CLB
CLB

Segment breakdown not available.

Related Comparisons